Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Universe Pharmaceuticals (UPC) Long-Term Deferred Tax (2020 - 2023)

Historic Long-Term Deferred Tax for Universe Pharmaceuticals (UPC) over the last 4 years, with Q3 2023 value amounting to -$948.0 million.

  • Universe Pharmaceuticals' Long-Term Deferred Tax fell 7044085.45% to -$948.0 million in Q3 2023 from the same period last year, while for Sep 2023 it was -$948.0 million, marking a year-over-year decrease of 7044085.45%. This contributed to the annual value of $599078.0 for FY2023, which is 5554.72% down from last year.
  • According to the latest figures from Q3 2023, Universe Pharmaceuticals' Long-Term Deferred Tax is -$948.0 million, which was down 7044085.45% from $830259.0 recorded in Q1 2023.
  • In the past 5 years, Universe Pharmaceuticals' Long-Term Deferred Tax ranged from a high of $186.5 billion in Q3 2020 and a low of -$948.0 million during Q3 2023
  • Moreover, its 4-year median value for Long-Term Deferred Tax was $927979.0 (2021), whereas its average is $30.9 billion.
  • Its Long-Term Deferred Tax has fluctuated over the past 5 years, first surged by 5490.54% in 2022, then crashed by 7044085.45% in 2023.
  • Quarter analysis of 4 years shows Universe Pharmaceuticals' Long-Term Deferred Tax stood at $186.5 billion in 2020, then crashed by 100.0% to $869997.0 in 2021, then soared by 54.91% to $1.3 million in 2022, then plummeted by 70440.85% to -$948.0 million in 2023.
  • Its Long-Term Deferred Tax stands at -$948.0 million for Q3 2023, versus $830259.0 for Q1 2023 and $1.3 million for Q3 2022.